Close Menu

NEW YORK, May 7 – Venlo, Netherlands-based Qiagen announced today that its net revenues and net income were up for the first quarter ending March 31.

The company reported net sales of $80 million, compared to $70.5 million for the year-ago quarter. The firm had net income of $11 million, compared to $9.5 million for the same quarter in 2002.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.